Endocrine-Related Cancer is an official journal of the Society for Endocrinology and is endorsed by the Endocrine Society of Australia.
The journal provides a unique international forum for the publication of high-quality original articles describing novel, cutting-edge basic laboratory, translational and clinical investigations of human health and disease. Endocrine-Related Cancer focusses on endocrine neoplasias and hormone-dependent cancers; and for the publication of authoritative review articles in these topics.
Endocrine neoplasias include adrenal cortex, breast, multiple endocrine neoplasia, neuroendocrine tumours, ovary, prostate, paraganglioma, parathyroid, pheochromocytoma pituitary, testes, thyroid and hormone-dependent cancers. Neoplasias affecting metabolism and energy production such as bladder, bone, kidney, lung, and head and neck, are also considered.
Endocrine-Related Cancer has a 2021 Impact Factor of 5.900, with a five year Impact Factor of 5.974.
Benefits to ESA members
Members of ESA are entitled to a 25% discount on colour and data charges when their paper is accepted for publication in Endocrine-Related Cancer.
Website: erc.bioscientifica.com
Endocrine Society of Australia
145 Macquarie Street
Sydney. NSW. 2000
Email: ijohnson@endocrinesociety.org.au
The Endocrine Society of Australia acknowledges the Australian Aboriginal and Torres Strait Islander peoples as the first inhabitants of the nation and the traditional custodians of the lands where we live, learn and work. We pay our respects to their Elders past, present and emerging.
